ArticleBreast (Edinburgh, Scotland)2015

Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab.

Arvind M Shinde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.